PLOD1 and central precocious puberty: This study aims to assess the feasibility of using urinary LH, assayed on the first-morning urine, as a biomarker of pubertal development, both in the initial diagnostic approach and the monitoring of patients with central precocious puberty undergoing therapy with GnRH analogues (GnRHa).